ARS Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 11.08 M | $160.63 M | 0.00% | 11.42% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 10.86 M | $157.48 M | 0.00% | 11.19% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 8.29 M | $120.18 M | -10.31% | 8.54% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.25 M | $61.57 M | 100.00% | 4.38% |
| SR ONE CAPITAL MANAGEMENT, LP | 11/13/2024 | 4.01 M | $58.19 M | 0.00% | 4.14% |
| VANGUARD GROUP INC | 11/13/2024 | 3.35 M | $48.56 M | 3.03% | 3.45% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 2.84 M | $42.42 M | -3.85% | 2.92% |
| NEXTECH INVEST LTD. | 11/14/2024 | 1.11 M | $16.14 M | -41.73% | 1.15% |
| FMR LLC | 11/13/2024 | 1.09 M | $15.75 M | 0.09% | 1.12% |
| WOODLINE PARTNERS LP | 11/14/2024 | 986,007 | $14.30 M | 250.71% | 1.02% |
| ROYCE & ASSOCIATES LP | 11/06/2024 | 691,455 | $10.03 M | 7.09% | 0.71% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 653,048 | $9.47 M | 78.90% | 0.67% |
| MORGAN STANLEY | 11/14/2024 | 638,622 | $9.26 M | 377.27% | 0.66% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 593,291 | $8.60 M | 100.00% | 0.61% |
| DUQUESNE FAMILY OFFICE LLC | 11/14/2024 | 536,900 | $7.79 M | 100.00% | 0.55% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 462,519 | $6.71 M | 2,842.23% | 0.48% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 400,000 | $5.80 M | 100.00% | 0.41% |
| CLARIVEST ASSET MANAGEMENT LLC | 11/12/2024 | 287,596 | $2.45 M | 0.00% | 0.30% |
| MIURA GLOBAL MANAGEMENT, LLC | 11/14/2024 | 270,000 | $3.92 M | 100.00% | 0.28% |
| LEVIN CAPITAL STRATEGIES, L.P. | 11/13/2024 | 269,426 | $3.91 M | 223.63% | 0.28% |
| EAM INVESTORS, LLC | 11/13/2024 | 261,649 | $3.79 M | 100.00% | 0.27% |
| CITADEL ADVISORS LLC | 11/14/2024 | 252,499 | $3.66 M | 178.21% | 0.26% |
| WEXFORD CAPITAL LP | 11/14/2024 | 248,347 | $3.60 M | 100.00% | 0.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 247,700 | $3.59 M | 637.20% | 0.26% |
| NEUBERGER BERMAN GROUP LLC | 11/14/2024 | 245,935 | $3.57 M | 100.00% | 0.25% |
| RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 204,783 | $2.97 M | 100.00% | 0.21% |
| NICHOLAS INVESTMENT PARTNERS, LP | 11/12/2024 | 201,771 | $2.93 M | 100.00% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 184,100 | $2.67 M | -81.69% | 0.19% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/18/2024 | 178,221 | $2.58 M | 100.00% | 0.18% |
| CITADEL ADVISORS LLC | 11/14/2024 | 161,200 | $2.34 M | 221.12% | 0.17% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 148,294 | $2.15 M | -38.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 147,291 | $2.14 M | 477.59% | 0.15% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 125,000 | $1.81 M | 100.00% | 0.13% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 125,000 | $1.81 M | 100.00% | 0.13% |
| K2 PRINCIPAL FUND, L.P. | 11/15/2024 | 120,000 | $1.74 M | -95.13% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 112,864 | $1.64 M | 4.43% | 0.12% |
| BARCLAYS PLC | 11/19/2024 | 111,666 | $1.62 M | 189.75% | 0.12% |
| UBS GROUP AG | 11/14/2024 | 109,882 | $1.59 M | 69.25% | 0.11% |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 11/12/2024 | 106,400 | $1.59 M | 100.00% | 0.11% |
| K2 PRINCIPAL FUND, L.P. | 11/15/2024 | 105,800 | $1.53 M | -26.48% | 0.11% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 98,900 | $1.43 M | 67.69% | 0.10% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2024 | 98,640 | $1.43 B | -58.37% | 0.10% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 98,449 | $1.43 M | 0.66% | 0.10% |
| JANE STREET GROUP, LLC | 11/15/2024 | 88,737 | $1.29 M | -22.42% | 0.09% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 85,295 | $1.24 M | 100.00% | 0.09% |
| FAS WEALTH PARTNERS, INC. | 10/17/2024 | 84,855 | $1.23 M | 25.42% | 0.09% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 11/14/2024 | 83,225 | $1.21 M | 100.00% | 0.09% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 81,275 | $1.18 M | -4.74% | 0.08% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/18/2024 | 78,779 | $1.14 M | 653.87% | 0.08% |
| MARSHALL WACE, LLP | 11/14/2024 | 77,879 | $1.13 M | 100.00% | 0.08% |
ARS Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 119 institutional investors and hedge funds held shares of ARS Pharmaceuticals, Inc.. The most heavily invested institutionals were:
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 11.08 M
RA CAPITAL MANAGEMENT, L.P.: 10.86 M
ORBIMED ADVISORS LLC: 8.29 M
BlackRock Funding, Inc. /DE: 4.25 M
SR ONE CAPITAL MANAGEMENT, LP: 4.01 M
VANGUARD GROUP INC: 3.35 M
66.02% of ARS Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 56.94 M shares in the last 24 months. This purchase volume represents approximately $637.75 M in transactions.